Resistance to erythropoietin-stimulating agents: Etiology, evaluation, and therapeutic considerations

Pediatric Nephrology

Volumn 27, Issue 2, 2012, Pages 195-205

  Bamgbola, Oluwatoyin ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Erythropoietin stimulating agents; Etiology; Evaluation; Resistantanemia; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIPYRETIC ANALGESIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DIALYSIS; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; ENVIRONMENTAL FACTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH PROMOTION; HEMOGLOBINOPATHY; HIGH RISK PATIENT; HUMAN; HYPERPARATHYROIDISM; INFLAMMATION; IRON DEFICIENCY; MALNUTRITION; OXIDATIVE STRESS; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT RESPONSE; VITAMIN D DEFICIENCY;

ANEMIA; CHILD; DRUG RESISTANCE; HEMATINICS; HUMANS; IRON; METALS, HEAVY; MICRONUTRIENTS; OXIDATIVE STRESS;

EID: 84857109530     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1839-4     Document Type: Review

References (65)

1. Locatelli F, Aljama P, Bárány P, Canaud B, Carrera F, Eckardt KU, Hörl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S, European Best Practice Guidelines Working Group (2002) Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19:Sii1-Sii47
2. Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U (2007) Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: A randomized trial. Am J Kidney Dis 50:989-1000 (Pubitemid 350122810)
3. Atkinson MA, Martz K, Warady BA, Neu AM (2010) Risk for anemia in pediatric chronic kidney disease patients: A report of NAPRTCS 2010. Pediatr Nephrol 25(9):1699-1706
4. Wazny LD, Stojimirovic BB, Heidenheim P, Blake PG (2002) Factors influencing erythropoietin compliance in peritoneal dialysis patients. Am J Kidney Dis 40:623-628 (Pubitemid 34971292)
5. KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S1-S145
6. Cody J, Daly C, CampbellM, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A (2002) Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database Syst Rev 4:CD003895
7. Irwing JJ, Kirchner JT (2001) Anemia in children. Am Fam Physician 61:1379-1386 (Pubitemid 32983374)
8. Schoorl M, Schoorl M, Nubé MJ, Bartels PC (2006) Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia. Clin Lab 52:621-629 (Pubitemid 44883590)
9. Gotloib L, Silverberg D, Fudin R, Shostak A (2006) Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol 19:161-167 (Pubitemid 44420105)
10. Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209-219
11. Van Wyck DB (2000) Management of early renal anaemia: Diagnostic work-up, iron therapy, epoetin therapy. Nephrol Dial Transplant 15:36-39
12. Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA (2001) Diagnostic value of iron indices in hemodialysis patients receiving epoetin. Kidney Int 60:300-308 (Pubitemid 32587568)
13. Agarwal AK (2007) Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc 7:S7-S12
14. Schiesser D, Binet I, Tsinalis D, Dickenmann M, Keusch G, Schmidli M, Ambühl PM, Lüthi L, Wüthrich RP (2006) Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrol Dial Transplant 21:2841-2845 (Pubitemid 44542240)
15. Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM(2001) Aprospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrol Dial Transplant 16:1879-1884 (Pubitemid 32821421)
16. Morgan HE, Holt RC, Jones CA, Judd BA (2007) Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin. Pediatr Nephrol 22:1963-1965 (Pubitemid 47506239)
17. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR (2007) Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 18:975-984 (Pubitemid 46434515)
18. Kapoian T, O'Mara NB, Singh AK, Moran J, Rizkala AR, Geronemus R, Kopelman RC, Dahl NV, Coyne DW (2008) Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol 19:372-379 (Pubitemid 351240658)
19. Port RE, Mehls O (2009) Erythropoietin dosing in children with chronic kidney disease: Based on body size or on hemoglobin deficit? Pediatr Nephrol 24:435-437
20. Kalocheretis P, Vlamis I, Belesi C, Makriniotou I, Zerbala S, Savidou E, Zorbas S, Arvanitis N, Iatrou C (2006) Residual blood loss in single use dialyzers: Effect of different membranes and flux. Int J Artif Organs 29:286-292 (Pubitemid 43833914)
21. Fabbian F, Catalano C, Bordin V, Balbi T, Di Landro D (2002) Esophagogastroduodenoscopy in chronic hemodialysis patients: 2-year clinical experience in a renal unit. Clin Nephrol 58:54-59 (Pubitemid 34752994)
22. Müller-Wiefel DE, Sinn H, Gilli G, Schärer K (1977) Hemolysis and blood loss in children with chronic renal failure. Clin Nephrol 8(5):481-486 (Pubitemid 8233939)
23. Tomori K, Nakamoto H, Kotaki S, Ishida Y, Takane H, Nemoto H, Kanno Y, Sugahara S, Okada H, Suzuki H (2003) Gastric angiodysplasia in patients undergoing maintenance dialysis. Adv Perit Dial 19:136-142
24. Ford-Jones AE, Cogswell JJ (1975) Tests for occult in stools of children. Arch Dis Child 50:238-240
25. Raju GS, Gerson L, Das A, Lewis B (2007) American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 133:1694
26. Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci V, Vaira D (2006) Accuracy of breath tests using low doses of 13Curea to diagnose Helicobacter pylori infection: A randomised controlled trial. Gut 55:457-462
27. Kyrlagkitsis I, Ladas SD, Mallass EG, Raptis S, Mentis A, Delliou E, Zizi-Serbetzoglou A, Elemenoglou I, Antonakopoulos N, Karamanolis DG (2007) Evaluation of a conventional ELISA (Novitec) and a near patient immunochromatographic test (Stick H. pyl) for Helicobacter pylori antigen detection in stool. Hepatogastroenterology 54:799-802 (Pubitemid 46903727)
28. Brooker S, Jardim-Botelho A, Quinnell RJ, Geiger SM, Caldas IR, Fleming F, Hotez PJ, Correa-Oliveira R, Rodrigues LC, Bethony JM (2007) Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg 101:146-154 (Pubitemid 44835344)
29. Bergström J, Lindholm B, Lacson E Jr, Owen W Jr, Lowrie EG, Glassock RJ, Ikizler TA, Wessels FJ, Moldawer LL, Wanner C, Zimmermann J (2000) What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 13:163-175
30. Macdougall IC, Cooper AC (2002) Erythropoietin resistance: The role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17 [Suppl 11]:S39-S43
31. Jacobs C (2006) Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients. Nat Clin Pract Nephrol 2:552-553 (Pubitemid 44465673)
32. Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M (2002) Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 26:366-370 (Pubitemid 34415549)
33. Gallieni M, Corsi C, Brancaccio D (2000) Hyperparathyroidism and anemia in renal failure. Am J Nephrol 20:89-96 (Pubitemid 30224017)
34. Al-Hilali N, Al-Humoud H, Ninan VT, Nampoory MR, Puliyclil MA, Johny KV (2007) Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract 16:63-67 (Pubitemid 44924460)
35. Meytes D, Shacked N, Blum M, Ramot B (1990) Effect of excess parathyroid hormone on human bone marrow fibroblasts. Nephron 55:6-9 (Pubitemid 20135094)
36. Nomura S, Ogawa Y, Osawa G, Katagiri M, Harada T, Nagahana H (1996) Myelofibrosis secondary to renal osteodystrophy. Nephron 72(4):683-687 (Pubitemid 26098274)
37. Brunner S, Theiss HD, Murr A, Negele T, Franz WM (2007) Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. Am J Physiol Endocrinol Metab 293:E1670-E1675 (Pubitemid 350255118)
38. Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME (2006) Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361-1372 (Pubitemid 44827918)
39. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB (2006) Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton) 11:394-399 (Pubitemid 44470086)
40. Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM (2008) Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery 144:915-918
41. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-S201
42. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42
43. Di Iorio B, Guastaferro P, Bellizzi V (2003) Relationship between resistance to erythropoietin and high anomalous hemoglobin levels in hemodialysis patients with beta-thalassemia minor. Blood Purif 21:376-380 (Pubitemid 37346711)
44. Das N, Das Chowdhury T, Chattopadhyay A, Datta AG (2004) Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol 56:85-96 (Pubitemid 38515290)
45. Roseff SD (2009) Sickle cell disease: A review. Immunohematology 25(2):67-74
46. Teuscher T, Baillod B, Holzer BR (1991) Prevalence of human parvovirus B19 in sickle cell disease and healthy controls. Trop Geogr Med 43:108-110
47. Mason PJ, Bautista JM, Gilsanz F (2007) G6PD deficiency: The genotype-phenotype association. Blood Rev 21:267-283 (Pubitemid 47212602)
48. Bamgbola OF, Kaskel F (2005) Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis. Pediatr Nephrol 20:1622-1629 (Pubitemid 41554477)
49. Bamgbola OF, Kaskel FJ, Coco M (2009) Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol 24:571-579
50. Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L (1988) Deficiencies of vitamins in CAPD patients: The effect of supplementation. Nephrol Dial Transplant 3:187-193
51. Phekoo K, Williams Y, Schey SA, Andrews VE, Dudley JM, Hoffbrand AV (1979) Folate assays: Serum or red cell? J R Coll Physicians Lond 31:291-295
52. Green R (2008) Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull 29:S52-S63
53. Koppel JD, Jones MR, Keshavia PR, Bergstrom J, Lindsay RM, Moran J, Nolph KD, Teehan BP (1995) A proposed glossary for dialysis kinetics. Am J Kidney Dis 26:963-981
54. Harty JC, Boulton H, Curwell J, Heelis N, Uttley L, Venning MC, Gokal R (1994) The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109 (Pubitemid 24045997)
55. Harty JC, Boulton H, Heelis N, Uttley L, Venning M, Gokal R (1993) Limitations of kinetic models as predictors of nutritional and dialysis adequacy in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 13:454-463 (Pubitemid 24041066)
56. Cano NJ, Miolane-Debouit M, Léger J, Heng AE (2009) Assessment of body protein: Energy status in chronic kidney disease. Semin Nephrol 29:59-66
57. Perez-Garcia R, Rodriguez-Benitez P (1999) Chloramine, a sneaky contaminant of dialysate. Nephrol Dial Transplant 14:2579-2582 (Pubitemid 32208365)
58. Sharples EJ, Varagunam M, Sinnott PJ, McCloskey DJ, Raftery MJ, Yaqoob MM (2006) The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 26:64-68 (Pubitemid 44339663)
59. Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85-118 (Pubitemid 30394534)
60. Kuypers DR, de Jonge H, Naesens M, de Loor H, Halewijck E, Dekens M, Vanrenterghem Y (2008) Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5- year, open-label, prospective, clinical follow-up study in renal allograft recipients. Clin Ther 30:673-683 (Pubitemid 351689045)
61. Malluche HH (2002) Aluminum and bone disease in chronic renal failure. Nephrol Dial Transplant 17(S2):21-24 (Pubitemid 34413721)
62. Schwartz KA (1985) Aluminum-induced anemia. Am J Kidney Dis 6(5):348-352 (Pubitemid 16219056)
63. Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ (2009) Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988-2004. Pediatrics 123(3):e376-e385
64. Patrick L (2006) Lead toxicity, a review of the literature. I. Exposure, evaluation, and treatment. Altern Med Rev 11(1):2-22
65. Oh RC, Brown DL (2003) Vitamin B12 deficiency. Am Fam Physician 67(5):979-986